Mar 14 |
Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years ago
|
Mar 13 |
Enzo Biochem Non-GAAP EPS of $0.00, revenue of $8.55M
|
Mar 13 |
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
|
Feb 1 |
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
|
Jan 30 |
Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)
|
Dec 18 |
HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday
|
Dec 15 |
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
|
Nov 6 |
Enzo Biochem GAAP EPS of $0.41
|
Nov 6 |
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
|
Oct 30 |
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
|